AI-Predicted Antimicrobial Compound Validation Against Pseudomonas aeruginosa
Project Overview Living In Silico Inc. is seeking a consultant or Contract Research Organization (CRO) with expertise in antimicrobial susceptibility testing to validate four AI-predicted small-molecule compounds against Pseudomonas aeruginosa. Our proprietary graph neural network (GNN) platform has identified several candidate compounds predicted to exhibit antibacterial activity against P. aeruginosa. We are now seeking experimental […]
Jenna Montgomery Harvey, PhD
I am a neuroscience drug discovery scientist with more than 15 years of experience spanning neurophysiology, neurodegenerative disease research, translational biology, and therapeutic development. Throughout my career, I have worked across academia, biotechnology, and pharmaceutical research, advancing programmes from target identification and validation through candidate nomination and early preclinical development. In recent years, I have […]
Gwang Jin (Josephus) Kim
Senior Data Scientist computational biologist PhD Molecular Medicine with long-term experience delivering end-to-end analytics across disease research and Pharma Biotech environments from multi-omics single-cell bulk RNA-seq ChIP/ATAC to applied ML CNNs sequence models and robust reproducible pipelines. Clinical-facing background from a university hospital setting Freiburg Germany worked with patient-derived cohort data under ethics approval informed […]